Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Pharm Pharmacol ; 53(9): 1281-6, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11578111

ABSTRACT

Encapsulation of drugs in intact erythrocytes, because of the profound characteristics of these natural microspheres, has gained considerable attention in recent years. In this study, the inhibition time courses of serum angiotensin-converting enzyme (ACE) activity after intravenous administration of enalaprilat encapsulated in intact erythrocytes was evaluated and compared with free drug, in a rabbit model. Three groups of animals each received free drug, drug-loaded erythrocytes or sham-encapsulated erythrocytes. Serum ACE activity was determined in each case using the synthetic substrate hippuryl-histidyl-leucine and quantitation of the hippuric acid released by a developed and validated HPLC method. The serum ACE inhibition profiles in the three groups showed that the encapsulated drug inhibited the serum ACE more slowly, more efficiently, over a considerably longer time and in a more reproducible manner, than the free drug or sham-encapsulated erythrocytes. We conclude that the erythrocytes can serve as efficacious slow-release drug carriers for enalaprilat in circulation.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Enalaprilat/pharmacology , Erythrocytes , Peptidyl-Dipeptidase A/metabolism , Animals , Delayed-Action Preparations , Enalaprilat/administration & dosage , Infusions, Intravenous , Kinetics , Microspheres , Rabbits , Reproducibility of Results
2.
Drug Deliv ; 8(4): 223-30, 2001.
Article in English | MEDLINE | ID: mdl-11757780

ABSTRACT

In vitro characteristics of the human erythrocytes loaded by enalaprilat have been evaluated. Erythrocytes obtained from a healthy volunteer were loaded by enalaprilat using the hypotonic preswelling method, and the loading parameters, drug-release kinetics, hematological indices, particle size distribution, scanning electron microscopy view, osmotic and turbulence fragilities, and deformability of the resulting carrier cells were determined along with the sham encapsulated and unloaded cells. Carrier erythrocytes, having acceptable loading parameters, released their drug content according to zero-order kinetics. Mean corpuscular hemoglobin and mean corpuscular hemoglobin content values of the cells decreased, particle size dispersion increased, the cells transformed to cup-form, the erythrocytes became more fragile against osmotic pressure and turbulent flow, and, finally, the deformability of the cells decreased significantly upon drug loading.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/chemistry , Enalaprilat/chemistry , Erythrocytes , Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Chromatography, High Pressure Liquid , Drug Carriers , Enalaprilat/administration & dosage , Erythrocyte Deformability , Erythrocytes/chemistry , Erythrocytes/cytology , Hemoglobins/analysis , Hemolysis , Humans , Hypotonic Solutions , In Vitro Techniques , Infusions, Intravenous , Male , Microscopy, Electron, Scanning , Osmotic Fragility , Particle Size
SELECTION OF CITATIONS
SEARCH DETAIL